Jeffrey Garro
Stock Analyst at Stephens
(0.07)
# 4,716
Out of 5,004 analysts
73
Total ratings
31.3%
Success rate
-23.8%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $8.04 | -12.94% | 6 | May 13, 2026 | |
| CERT Certara | Reiterated: Buy | $12 → $9 | $9.11 | -1.21% | 6 | May 12, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $2 → $1.75 | $1.74 | +0.57% | 5 | May 12, 2026 | |
| PHR Phreesia | Reiterated: Buy | $37 → $20 | $10.15 | +97.04% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $5 → $3 | $0.945 | +217.46% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $7 | $3.61 | +93.91% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Reiterated: Buy | $28 → $20 | $18.46 | n/a | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Reiterated: Hold | $8 | $6.09 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Reiterated: Buy | $26 → $30 | $19.71 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Reiterated: Hold | $13 → $7 | $5.00 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $26.35 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $270.37 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $280.68 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $8.21 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 → $3.9 | $9.00 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.40 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $137.10 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $8.04
Upside: -12.94%
Certara
May 12, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $9.11
Upside: -1.21%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $2 → $1.75
Current: $1.74
Upside: +0.57%
Phreesia
Mar 31, 2026
Reiterated: Buy
Price Target: $37 → $20
Current: $10.15
Upside: +97.04%
Definitive Healthcare
Feb 27, 2026
Reiterated: Hold
Price Target: $5 → $3
Current: $0.945
Upside: +217.46%
Evolent Health
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $3.61
Upside: +93.91%
Simulations Plus
Jul 15, 2025
Reiterated: Buy
Price Target: $28 → $20
Current: $18.46
Upside: n/a
Teladoc Health
Apr 30, 2025
Reiterated: Hold
Price Target: $8
Current: $6.09
Upside: n/a
Privia Health Group
Mar 5, 2025
Reiterated: Buy
Price Target: $26 → $30
Current: $19.71
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $5.00
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $26.35
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $270.37
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $280.68
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $15 → $20
Current: $8.21
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: $5 → $3.9
Current: $9.00
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $4 → $3
Current: $0.40
Upside: n/a
Dec 20, 2021
Reiterated: Buy
Price Target: n/a
Current: $137.10
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a